Markets · Stocks & ETFs · ADR

Ambev S.A. (NYSE: ABEV)

$3.03-0.66%today

Brazilian ADR trading on the NYSE, priced in US dollars. Key figures below are sourced from Yahoo Finance.

Market Cap
$46.82B
P/E (TTM)
15.9x
P/B
2.7x
EPS (TTM)
0.19
Dividend Yield
5.54%
52-Week Range
$2.10 – $3.45
Volume
14.64M
Previous Close
$3.05

TTM = trailing twelve months — the most recent 12 months (a rolling window), used for P/E, EPS and dividends. On the tables and charts below, the in-progress current year appears as a “Last 12M” column labelled with the quarter range it covers.

Performance

Today
-0.66%
1 Week
-1.30%
1 Month
-2.88%
YTD
+22.67%
1 Year
+28.94%
5 Years
-5.61%

About Ambev S.A.

US Ticker
ABEV
B3 Ticker
ABEV3
Exchange
NYSE
Currency
USD
Sector
Consumer Defensive
Industry
Beverages - Brewers
Headquarters
São Paulo, SP, Brazil
Employees
39,000
CEO
Mr. Carlos Eduardo Klutzenschell Lisboa
Founded
1853

Ambev S.A., through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, soft drinks, malt and food, and other beverages in Brazil, Central America and Caribbean, Latin America South, and Canada.

The company offers beer, ready-to-drink cocktails and spritzers, soft drinks, water, teas, and isotonic drinks under the Brahma, Skol, Antarctica, Original, Quilmes, Andes Origen, Patricia, Paceha, Huari, Pilsen, Presidente, Balboa, Guaraná Antarctica, and Beats brands.

It sells its products to distributors, supermarkets, and retailers within a broad distribution network.

The company was founded in 1853 and is headquartered in São Paulo, Brazil.

Ambev S.A. operates as a subsidiary of Interbrew International B.V.

www.ambev.com.br

Analyst Ratings

Consensus of 10 Wall Street analysts · sourced from Yahoo Finance

3.0Hold

On a 1–5 scale: 1 = Strong Buy, 3 = Hold, 5 = Sell. Lower is more bullish.

12-Month Price Target

Low
$2.55
Average
$3.37
High
$4.00

The average target is +11.33% above the current price of $3.03.

Display currency
Revenue, net debt and other totals below — switch between US dollars and BRL.

Financial Results

Revenue, EBITDA and net profit (in USD) with net margin (net profit ÷ revenue).

Financial Health

Margins, leverage and cash-flow quality derived from Ambev S.A.'s income statement, balance sheet and cash flow (absolute figures in USD).

ProfitabilityLeverageGrowth

Overall: Financially Strong

Net Margin
17.7%
ROE
17.3%
Rev Growth (YoY)
-0.04%
Net Debt / EBITDA
-0.51×
Current Ratio
1.03×
Interest Coverage
8.09×
Free Cash Flow
22.15B
Payout Ratio
88.9%

Income — Margins & Efficiency

MetricLast 12MQ2'25 – Q1'26Δ2025Δ2024Δ2023Δ2022
Revenue$16,986,905,330+5.4%$16,113,819,802+11.3%$14,479,467,133-11.9%$16,439,920,003+9.0%$15,083,222,950
Gross profit$8,744,727,507+5.5%$8,286,476,024+11.7%$7,419,608,605-11.0%$8,338,893,242+12.2%$7,434,186,126
Operating income$4,615,086,273+13.2%$4,076,293,780+15.5%$3,528,982,340-9.1%$3,882,520,308+16.0%$3,347,046,134
EBITDA$5,578,730,357+5.4%$5,290,986,450+12.7%$4,696,077,955-6.2%$5,003,814,276+14.5%$4,368,296,560
Net profit$2,999,868,472+6.0%$2,831,050,729+21.1%$2,336,910,601-21.8%$2,989,959,177+9.3%$2,735,855,126
Gross margin51.5%+0.1 p.p.51.4%+0.2 p.p.51.2%+0.5 p.p.50.7%+1.4 p.p.49.3%
Operating margin27.2%+1.9 p.p.25.3%+0.9 p.p.24.4%+0.8 p.p.23.6%+1.4 p.p.22.2%
EBITDA margin32.8%+0.0 p.p.32.8%+0.4 p.p.32.4%+2.0 p.p.30.4%+1.5 p.p.29.0%
Net margin17.7%+0.1 p.p.17.6%+1.4 p.p.16.1%-2.0 p.p.18.2%+0.0 p.p.18.1%
Revenue growth (YoY)-0.0%+1.3 p.p.-1.4%-13.5 p.p.12.2%+12.1 p.p.0.0%-9.4 p.p.9.4%
Effective tax rate17.6%-0.1 p.p.17.7%-6.1 p.p.23.8%+23.3 p.p.0.5%+5.1 p.p.-4.6%
Interest coverage8.09×-0.6%8.14×-10.8%9.13×-70.4%30.86×+7.4%28.73×

Newest column (“Last 12M”) = trailing 12 months, the last 4 reported quarters — shown with the quarter range it spans; earlier columns are full fiscal years.

Balance Sheet — Health & Leverage

MetricLast 12MQ2'25 – Q1'26Δ2025Δ2024Δ2023Δ2022
Net debt-$2,866,689,069-18.1%-$2,426,617,362+40.4%-$4,069,829,554-57.2%-$2,589,150,963-23.5%-$2,096,923,135
Net Debt / Equity-0.17×-9.3%-0.15×+40.7%-0.25×-60.3%-0.16×-17.6%-0.14×
Net Debt / EBITDA-0.51×-12.0%-0.46×+47.1%-0.87×-67.5%-0.52×-7.8%-0.48×
Debt / Equity0.03×-43.4%0.06×+73.8%0.04×-21.1%0.04×-5.5%0.05×
Current ratio1.03×+6.8%0.96×-12.2%1.10×+23.0%0.89×-4.4%0.93×
Return on equity (ROE)17.3%-0.4 p.p.17.6%+3.0 p.p.14.6%-3.7 p.p.18.4%+0.7 p.p.17.6%
Return on assets (ROA)10.9%+0.4 p.p.10.5%+1.6 p.p.8.9%-2.0 p.p.10.9%+0.5 p.p.10.5%
Book value / share$1.11+8.2%$1.02+1.4%$1.01-1.8%$1.03+5.1%$0.98

Newest column (“Last 12M”) = trailing 12 months, the last 4 reported quarters — shown with the quarter range it spans; earlier columns are full fiscal years.

Net Debt & Leverage

Free Cash Flow

Margins

Dividend Payout Ratio

Capex ÷ Revenue

Cash Conversion (operating cash flow ÷ net income)

Ratios computed from company financial statements. Net Debt = total debt − cash & equivalents; FCF = operating cash flow − capital expenditure; absolute values in USD.

Valuation & Dividends

P/E Ratio History

Dividend History

This year (YTD) $0.01/share · yield 0.30%

Dividends and yield from Yahoo Finance (per ADR share, in USD). The current-year figures are calendar year-to-date (dividends actually paid this year), not the trailing 12 months.

Listings

Ambev S.A. trades on 5 exchanges. Prices on this page are the NYSE ADR (ABEV).

ExchangeTickerCurrency
NYSEpriced hereABEVUSD
B3 (São Paulo)ABEV3BRL
FrankfurtAMNAEUR
Mexico (BMV)ABEVMXN
Buenos Aires (BYMA)ABEVARS

Last updated: 02:27 BRT · Updated hourly during market hours